These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 27243039)
1. Clinical Relevance of HLA Gene Variants in HBV Infection. Wang L; Zou ZQ; Wang K J Immunol Res; 2016; 2016():9069375. PubMed ID: 27243039 [TBL] [Abstract][Full Text] [Related]
2. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. Akcay IM; Katrinli S; Ozdil K; Doganay GD; Doganay L World J Gastroenterol; 2018 Aug; 24(30):3347-3360. PubMed ID: 30122875 [TBL] [Abstract][Full Text] [Related]
3. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Li X; Liu W; Wang H; Jin X; Fang S; Shi Y; Liu Z; Zhang S; Yang S Virus Res; 2012 Jan; 163(1):328-33. PubMed ID: 22056847 [TBL] [Abstract][Full Text] [Related]
4. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. Singh R; Kaul R; Kaul A; Khan K World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Yu L; Cheng YJ; Cheng ML; Yao YM; Zhang Q; Zhao XK; Liu HJ; Hu YX; Mu M; Wang B; Yang GZ; Zhu LL; Zhang S Sci Rep; 2015 Oct; 5():14933. PubMed ID: 26462556 [TBL] [Abstract][Full Text] [Related]
6. Host genetic variants influencing the clinical course of hepatitis B virus infection. Matsuura K; Isogawa M; Tanaka Y J Med Virol; 2016 Mar; 88(3):371-9. PubMed ID: 26255971 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082 [TBL] [Abstract][Full Text] [Related]
8. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689 [TBL] [Abstract][Full Text] [Related]
9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression. Zeng Z; Liu H; Xu H; Lu H; Yu Y; Xu X; Yu M; Zhang T; Tian X; Xi H; Guan L; Zhang J; O'Brien SJ; BMC Med Genomics; 2021 Mar; 14(1):84. PubMed ID: 33736632 [TBL] [Abstract][Full Text] [Related]
11. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy. Tseng TC; Yu ML; Liu CJ; Lin CL; Huang YW; Hsu CS; Liu CH; Kuo SF; Pan CJ; Yang SS; Su CW; Chen PJ; Chen DS; Kao JH Antivir Ther; 2011; 16(5):629-37. PubMed ID: 21817184 [TBL] [Abstract][Full Text] [Related]
12. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Rebbani K; Ezzikouri S; Marchio A; Ababou M; Kitab B; Dejean A; Kandil M; Pineau P; Benjelloun S Infect Genet Evol; 2014 Aug; 26():1-7. PubMed ID: 24797387 [TBL] [Abstract][Full Text] [Related]
13. Association between chronic hepatitis B virus infection and HLA-DP gene polymorphisms in the Turkish population. Akgöllü E; Bilgin R; Akkız H; Ülger Y; Kaya BY; Karaoğullarından Ü; Arslan YK Virus Res; 2017 Mar; 232():6-12. PubMed ID: 28119119 [TBL] [Abstract][Full Text] [Related]
14. HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection. Lam YF; Wong DK; Seto WK; To KK; Hung IF; Fung J; Lai CL; Yuen MF J Gastroenterol Hepatol; 2014 Mar; 29(3):533-9. PubMed ID: 23980639 [TBL] [Abstract][Full Text] [Related]
15. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population. Wang T; Shen C; Chen L; Liu S; Ji Y J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28940887 [TBL] [Abstract][Full Text] [Related]
16. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. Cheong JY; Shin HD; Kim YJ; Cho SW J Med Virol; 2013 May; 85(5):808-14. PubMed ID: 23508906 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma. Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393 [TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
19. Natural history and prognosis of hepatitis B. Fattovich G Semin Liver Dis; 2003 Feb; 23(1):47-58. PubMed ID: 12616450 [TBL] [Abstract][Full Text] [Related]
20. What can we learn from hepatitis B virus clinical cohorts? Lin CL; Tseng TC; Kao JH Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]